Page 11 - Annual Report - Summative Report 2024-2025
P. 11

REPORT OF THE CHIEF EXECUTIVE OFFICER & PRESIDENT



            General financial review                           SAMRC generated a net surplus for the year of R60 666
                                                               compared to an approved budget deficit of R Zero. This
            (All figures R’000, prior year in parenthesis.)
                                                               surplus  was  generated  from  an  underspent  of  R39m
            Revenue  for  the  year  showed  an  increase  of  4.6%  to   under baseline funded activities and income generated
            R1  408  845  (R1  347  255).  This  consists  of  an  increase   from  contract  funded  activities  of  R21m.  Revenue  was
            in  government  grants  of  9.65%  to  R724  161  (R660  413)   R343 756 under budget and expenditure was R404 422
            offset  by  a  decrease  in  contract  income  of  0.3%  to   under  budget.  The  under-recovery  on  revenue  was
            R684 684 (R686 842). Other income has increased by 29.8%   mainly  due  to  lower  than  anticipated  contract  funded
            to R26 792 (R20 648) due to an increase in conference and   research revenue towards the end of the financial year,
            seminar  activities  and  recoupment  of  research  grants.   especially  the  start  of  quarter  4  when  the  SAMRC  was
            Operating  expenses  reflected  a  decrease  of  1%  to   issued  with  stop  work  orders  from  the  USA  Federal
            R1 430 555 (R1 451 905).                           Government on Federal funded projects. The impact of
                                                               this stop work order resulted in lower than the expected
            The  preceding  has  resulted  in  an  operating  surplus  of   revenue  and  expenditure  on  contract  funded  research
            R5 083 for the year compared to an operating deficit of   activities.  Baseline  funded  projects  activities  spending
            R84 001 of the previous financial year 2023/24. The surplus   was also lower than anticipated which contributed to the
            is  the  result  of  the  9.65%  increase  in  the  government   surplus of R39m. Staff Expenditure, Laboratory expenses
            grant  and  a  decrease  of  14%  in  Collaborative  research   and Collaborative research costs were R15 569, R13 500
            expenditure  resulting  in  an  overall  decrease  in  total   and R246 823 under budget respectively due mainly to
            operating expenses by 1%.                          reduced  contract  funded  research  projects  activities
                                                               which did not happen partly due to the stop work order
            The  organisation  remains  financially  strong  with   issued  by  the  USA  Federal  Government  on  Federal
            accumulated reserves of R473 614 (R412 948). Total assets   funded projects.
            have  increased  by  17%  to  R1  182  631(R1  009  310)  due
            mainly  to  an  increase  in  cash  and  cash  equivalents  of
            R157 724 and an increase in Property, Plant and Equipment   Requests for roll over of funds
            of  R27  260  due  to  increased  capital  expenditure  on
            Buildings.  Deferred  income  has  increased  by  R90  119   The  organisation  remains  financially  strong  with
            to  R538  756  (R448  637)  due  to  earning  more  contract   accumulated  reserves  of  R473  614  (R412  948).  The
            funding in the reporting period.                   necessary  approvals  will  be  sought  for  the  rollover  of
                                                               funds received from Government but not yet spent.
            SAMRC  generated  a  positive  operating  cashflow  of
            R222 844 compared to a negative operating cashflow of   Supply chain management
            R142 334 in the prior period due mainly to an increase in
            cash and a decrease in payments to suppliers. Net cash   There  were  no  unsolicited  bid  proposals  received
            flows from investing activities were negative, representing   during the year. The revised Materiality Framework was
            cash  outflow  due  mainly  to  capital  expenditure  of   approved by the Minister.
            R60  193  (R43  423).  The  net  impact  of  the  above  is  an
            increase  of  R157  774  in  cash  and  cash  equivalents   Audit report matters
            compared to a decrease of R195 708 in cash and cash
            equivalents in the prior year.                     There were no matters to report.

            Trends                                             Events after the reporting date

            Operating  expenses  reflected  a  decrease  of  1%  to   No significant events were identified after the reporting
            R1  430  555  (R1  451  905).  This  is  mainly  the  result  of   date that may have an impact on the financial statements.
            a  decrease  in  collaborative  research  expenditure  of
            R77  125,  offset  by  an  increase  in  employee  costs  of   Economic viability
            R47 299. Employee related costs have increased by 8.5%
            to R599 247 (R551 948) driven mainly by basic salary costs   Funding allocations of R765 298 for 2025/26 have been
            which have increased by 9% to R486 275 (R445 861). This   approved  by  the  Government.  This  together  with
            increase is directly linked to the increase in permanent staff   accumulated  reserves  of  R473  614  and  the  increase
            numbers, 830 (794). This translates to an average increase   anticipated in the value of grants received will ensure that
            of 4.2% per staff member. Employee related costs include   the SAMRC will continue to operate as a going concern.
            net bonus provision costs of R15 319 (R15 815).



                                                                   SUMMA
                                                                          TIVE REPOR
                                                  SAMRC  SUMMATIVE REPOR T 2025-26T 2024-25            11
                                                          SAMRC
   6   7   8   9   10   11   12